GRAIL to start REACH study of Galleri multi-cancer early detection test

By NS Medical Staff Writer

21 Nov 23

The trial is intended to assess and compare the group of Medicare beneficiaries who undergo standard care along…

DevicesDiagnostic DevicesIn vitro Diagnostic

Universal DX, Quest partner to introduce Signal-C colorectal cancer test in US

By NS Medical Staff Writer

21 Nov 23

UDX’ Signal-C is designed to detect methylation DNA patterns and fragments released by circulating colorectal cancer tumours in…

DevicesDiagnostic DevicesIn vitro Diagnostic

Geneoscopy, Labcorp sign distribution pact for colorectal cancer screening test

By NS Medical Staff Writer

15 Nov 23

The next-generation screening test of Geneoscopy is a multi-target stool RNA biomarker panel, designed to identify colorectal cancer…

DevicesDiagnostic DevicesIn vitro Diagnostic

Oxford Nanopore, DZD to develop new bloodstream infections diagnostics

By NS Medical Staff Writer

15 Nov 23

Both companies will work together to integrate and improve a diagnostic system to be used in clinical environments…

DevicesDiagnostic DevicesIn vitro Diagnostic

Lucid Diagnostics launches EsoGuard 2.0 for esophageal precancer detection

By NS Medical Staff Writer

10 Nov 23

The EsoGuard Esophageal DNA test is intended to help in preventing cancer and associated death through early detection…

DevicesIn vitro Diagnostic

Velsera, Solaris collaborate to expand access to genetic testing for cancer patients

By NS Medical Staff Writer

06 Nov 23

Under the partnership, affiliates of Solaris Health will use Velsera’s Clinical Genomics Workspace platform to provide inherited cancer…

Diagnostic DevicesIn vitro Diagnostic

YourBio Health’s TAP Micro Select blood collection device obtains CE Marking

By NS Medical Staff Writer

01 Nov 23

GMED, a French Notified Body specialising in medical device assessments, issued the certification contract authorising the use of…

DevicesIn vitro Diagnostic

Lucent rolls out p-Tau 217 blood-based biomarker test for Alzheimer’s disease

By NS Medical Staff Writer

25 Oct 23

The LucentAD p-Tau 217 test leverages a combination of Quanterix’ Simoa technology and J&J Innovative Medicine’s p-Tau 217…

Diagnostic DevicesIn vitro Diagnostic

FloBio gets FDA breakthrough status for rapid bleeding risk diagnostic test

By NS Medical Staff Writer

18 Oct 23

The Philadelphia-based FloBio has designed the precision, point-of-care test Direct Oral Anticoagulant detection test to aid emergency medical…

DevicesDiagnostic DevicesIn vitro Diagnostic

Werfen gets FDA clearance for Aptiva CTD Essential reagent

By NS Medical Staff Writer

17 Oct 23

The Aptiva CTD Essential reagent can generate a throughput of up to 600 results per hour to streamline…

Diagnostic DevicesIn vitro Diagnostic